Analysis, trends and data stories from the Clival team, newest first.
Featured
India makes a lot of medicine. A LOT. It ships pills, syrups, and injections to more than 200 countries.
Read article
Data is no longer optional. It is the engine of modern drug development. The question is whether your organization is driving it, or being left behind by it.
Read article
Biologic medicines changed modern healthcare. They treat complex diseases like cancer, autoimmune disorders, and diabetes.
Read article
Pharma R&D waste is often mistaken for scientific failure. In reality, a large portion of it is strategic and preventable.
Read article
The generic injectable market is not glamorous. It is not trendy either. But it prints money.
Read article
The biosimilar market is getting bigger, faster, and honestly a little chaotic. Patent cliffs are coming one after another, biologics are losing exclusivity across the world, and every pharma company wants a piece of the action.
Read article
Discover the latest trends in drug discovery and development for 2026, including AI-driven research, advanced clinical trial technologies, precision medicine innovations, and emerging pharma strategies shaping the future of healthcare.
Read article
Bottom line is, 2026 will is going to be one of the most important years for healthcare sector. So let’s dive in, and get a better look at what next year have up it’s sleeves.
Read article
Explore how Phase I drug formulations transition from lab research to human testing, shaping the foundation for safe and effective clinical development.
Read article
The global herbal medicine market is booming, and at its heart lies Traditional Chinese Medicine (TCM).
Read articlePage 3 of 9 · 83 articles